Biotech Values

[DewDiligence]

What effect do you think Lemtrada will have on the MS market? I could see it impacting Rebif and Avonex sales to some extent.

On a relative basis, I think Lemtrada will affect Tysabri more than any other MS drug; however, Tysabri’s market share is pretty small, so on an absolute basis, Lemtrada will probably have a larger impact on Rebif, Avonex, and Copaxone.